home
about us
delivery platforms
product pipeline
subsidiaries
news and events
contact us
about us
about us
careers
benefits
current openings
fact sheet
history
leadership
recent news
MicroDose Therapeutx Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV)
fact sheet
Download a pdf of our Fact Sheet